In murine models of CT26 colorectal carcinoma, monotherapy with anti-TIGIT therapy did not effect tumor growth; however, when introduced with anti-PD-1 it resulted in a reduction of tumor growth (38). The gene discussed is TIGIT; the disease is neoplasm.